Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreHarness unparalleled healthcare data, advanced analytics, and cutting-edge technologies with our expertise to accelerate the development and commercialization of innovative medicines, enhancing patient lives.
Discover MoreBoost your innovation with IQVIA's expert team. Our comprehensive solutions integrate top-tier insights, technology, and expertise to maximize your asset's success in a competitive landscape.
Discover InnovationsNavigating MedTech's unique landscape: U.S. decision-making now rests with GPOs, IDNs, and payers, who demand solid value proof through rigorous outcomes analyses and pricing scrutiny.
Explore MedTechInvest in healthcare with confidence. Stay ahead of pharma and medical device trends using real-time, high-quality data. Access market insights, historical sales, prescription trends, and emerging product information for informed, risk-reduced decisions.
Access InsightsUnlock deeper health insights with unmatched data and innovative technology to enhance decision-making for your essential government programs.
Unlock InnovationsAccelerate digital innovation with our data-driven expertise in data science and healthcare, optimizing business processes for smarter decisions.
Navigate Health PlansLeverage digital innovation to cut costs, boost efficiency, and elevate patient engagement, all while enhancing quality and health outcomes.
Streamline DecisionsEnhance your ability to evaluate and forecast population risk swiftly and accurately by integrating unmatched data, expertise, and technology.
Uncover MoreEmbrace digital innovation in healthcare to make more informed decisions and advance your mission as a data-driven organization.
Explore NowA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS"Words Matter: Use Sentiment Analysis to Understand and Improve the Patient Experience
READ MOREThis is the second paper in our 2-part analysis on managing operating expenses in the new investment environment. In Part 1, our research focused on the traits of successful products launched by emerging biopharma companies (EBP) under the 505(b)(2) regulatory pathway. This analysis focused on financial metrics to measure success, mainly cumulative breakeven, which compared total lifecycle commercial spend against total net revenue.
In Part 2 of our analysis, we shifted our focus to EBP products launched as new chemical entities (NCEs) and Biologics License Applications (BLAs). And, while we have applied the same methodology to measure financial success, we expanded our scope to also incorporate insights into the commercial strategies behind the finances of these products. Download the white paper now to read the full analysis.
Flexible solutions. Responsive teams. Data-driven insights.